CBLI Financial Facts
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14KLOSS FROM OPERATIONS: -714.13K
See Full Income Statement
Accrued expenses: 1.25M
Deferred revenue: 0
See Full Balance Sheet
Cleveland Biolabs, Inc. (CBLI) Earnings
|
Expand Research on CBLI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +38.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/16/21 |  |
Q221 | -$0.04 | N/A | N/A | N/A | N/A | N/A |  | | Details |
8/14/17  |
Q217 | -$0.50 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 8/15/16 | Q216 | -$0.17 | N/A | N/A | $575.03K | $329.91K | N/A | | | Details | |
| 5/16/16 | Q116 | -$0.06 | N/A | N/A | $12.5K | $607.3K | N/A | | | Details | |
| 11/5/15 |
|
Q315 | -$0.31 | N/A | N/A | $501K | $415M | N/A | | | Details |
| 8/12/15 |
|
Q215 | -$1.12 | N/A | N/A | $329.9M | $562.1M | N/A | | | Details |
| 5/6/15 |
|
Q115 | -$1.14 | N/A | N/A | $607.33K | $1.33M | N/A | | | Details |
| 2/24/15 |
|
Q114 | -$1.02 | N/A | N/A | $1.39M | $3.87M | N/A | | | Details |
